Adenovirus E4orf4 induces HPV-16 late L1 mRNA production

Virology

Volumn 383, Issue 2, 2009, Pages 279-290

  Somberg, Monika ^a   Rush, Margaret ^a   Fay, Joanna ^b   Ryan, Fergus ^b   Lambkin, Helen ^b   Akusjärvi, Göran ^a   Schwartz, Stefan ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

Adenovirus; ASF SF2; E4orf4; HPV; Splicing

Indexed keywords

MESSENGER RNA; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN ASF; PROTEIN E4ORF4; PROTEIN L4 33K; PROTEIN SF2; PROTEIN SR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA SPLICING;

CAPSID PROTEINS; GENE EXPRESSION REGULATION; HELA CELLS; HUMAN PAPILLOMAVIRUS 16; HUMANS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PROTEIN BINDING; PROTEIN PHOSPHATASE 2; RNA, MESSENGER; RNA, VIRAL; VIRAL PROTEINS;

ADENOVIRIDAE; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 58149116568     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.09.041     Document Type: Article

References (56)

1. Akusjärvi G., and Stevenin J. Remodelling of the host cell RNA splicing machinery during an adenovirus infection. Curr. Top. Microbiol. Immunol. 272 (2003) 253-286
2. Andrew E.M., and DiMaio D. Hierarchy of polyadenylation site usage by bovine papillomavirus in transformed cells. J. Virol. 67 (1993) 7705-7710
3. Baker C.C. Posttranscriptional regulation of papillomavirus gene expression. In: Billakanti S.R., Calef C.E., Farmer A.D., Halpern A.L., and Myers G.L. (Eds). Human Papillomaviruses: a Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Theoretical biology and biophysics (1997), Los Alamos national laboratory, Los Alamos
4. Baker C., and Calef C. Maps of papillomavirus mRNA transcripts. In: Billakanti S.R., Calef C.E., Farmer A.D., Halpern A.L., and Myers G.L. (Eds). Human Papillomaviruses: a Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Theoretical biology and biophysics (1997), Los Alamos National Laboratory, Los Almos
5. Branton P.E., and Roopchand D.E. The role of adenovirus E4orf4 protein in viral replication and cell killing. Oncogene 20 (2001) 7855-7865
6. Cartegni L., Wang J., Zhu Z., Zhang M.Q., and Krainer A.R. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31 13 (2003) 3568-3571
7. Collier B., Goobar-Larsson L., Sokolowski M., and Schwartz S. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J. Biol. Chem. 273 35 (1998) 22648-22656
8. Collier B., Öberg D., Zhao X., and Schwartz S. Specific inactivation of inhibitory sequences in the 5′ end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells. J. Virol. 76 (2002) 2739-2752
9. Dauksaite V., and Akusjärvi G. Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing. J. Biol. Chem. 277 15 (2002) 12579-12586
10. Doorbar J. The papillomavirus life cycle. J. Clin. Virol. 32 Suppl 1 (2005) S7-15
11. Estmer Nilsson C., Petersen-Mahrt S., Durot C., Shtrichman R., Krainer A.R., Kleinberger T., and Akusjärvi G. The adenovirus E4-ORF4 splicing enhancer protein interacts with a subset of phosphorylated SR proteins. EMBO J. 20 4 (2001) 864-871
12. Fan, S. (2001). Viral strategies to regulate transcription and pre-mRNA splicing. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 0282-7476; 1003.
13. Fay, J., Kelehan, P., Lambkin, H., Schwartz, S., in press. Increased expression of cellular RNA-binding proteins in HPV-induced neoplasia and cervical cancer. J. Med. Virol.
14. Ser(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes. Nucleic Acids Res. 32 (2004) 4448-4461
15. Hertel K.J., and Graveley B.R. RS domains contact the pre-mRNA throughout spliceosome assembly. Trends Biochem. Sci. 30 3 (2005) 115-118
16. Howley P.M., and Lowy D.R. Papillomaviridae and their replication. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Virology Vol. 2 (2001), Lippincott/The Williams and Wilkins Co., Philadelphia, Pa 2197-2229
17. Kanopka A., Mühlemann O., and Akusjärvi G. Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature 381 6582 (1996) 535-538
18. Kanopka A., Mühlemann O., Petersen-Mahrt S., Estmer C., Öhrmalm C., and Akusjärvi G. Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature 393 (1998) 185-187
19. Karni R., de Stanchina E., Lowe S.W., Sinha R., Mu D., and Krainer A.R. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat. Struct. Mol. Biol. 14 3 (2007) 185-193
20. Kennedy I.M., Haddow J.K., and Clements J.B. A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J. Virol. 65 4 (1991) 2093-2097
21. Kleinberger T. Induction of apoptosis by adenovirus E4orf4 protein. Apoptosis 5 (2000) 211-215
22. Kornitzer D., Sharf R., and Kleinberger T. Adenovirus E4orf4 protein induces PP2A-dependent growth arrest in Saccharomyces cerevisiae and interacts with the anaphase-promoting complex/cyclosome. J. Cell. Biol. 154 2 (2001) 331-344
23. Lambert P.F., Ozbun M.A., Collins A., Holmgren S., Lee D., and Nakahra T. Using an immortalised cell line to study the HPV life cycle in organotypic "raft" cultures. Methods Mol. Med. 119 (2005) 141-155
24. Lee J.H., Yi S.M., Anderson M.E., Berger K.L., Welsh M.J., Klingelhutz A.J., and Ozbun M.A. Propagation of infectious HPV-16 using an adenovirus and Cre/LoxP mechanism. Proc. Natl. Acad. Sci. USA 101 (2004) 2094-2099
25. McLaughlin-Drubin M.E., and Meyers C. Propagation of infectious, high-risk HPV in organotypic "raft" culture. Methods Mol. Med. 119 (2005) 171-186
26. McPhillips M.G., Veerapraditsin T., Cumming S.A., Karali D., Milligan S.G., Boner W., Morgan I.M., and Graham S.V. SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells. J. Virol. 78 19 (2004) 10598-10605
27. Mole S., Veerapraditsin T., McPhilips M.G., and Graham S.V. Regulation of splicing-associated SR proteins by HPV-16. Biochem. Soc. Trans. 34 (2006) 1145-1147
28. Molin M., and Akusjärvi G. Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation. J. Virol. 74 19 (2000) 9002-9009
29. Öberg D., Collier B., Zhao X., and Schwartz S. Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells. J. Virol 77 (2003) 11674-11684
30. Öberg D., Fay J., Lambkin H., and Schwartz S. A downstream polyadenylation element in human papillomavirus type 16 encodes multiple GGG-motifs and interacts with hnRNP H. J. Virol. 79 14 (2005) 9254-9269
31. Pallas D.C., Shahrik L.K., Martin B.L., Jaspers S., Miller T.B., Brautigan D.L., and Roberts T.M. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60 1 (1990) 167-176
32. Pim D., Massimi P., Dilworth S.M., and Banks L. Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A. Oncogene 24 (2005) 7830-7838
33. Reimann J.D., Freed E., Hsu J.Y., Kramer E.R., Peters J.M., and Jackson P.K. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell 105 5 (2001) 645-655
34. Rollman E., Arnheim L., Collier B., Öberg D., Hall H., Klingström J., Dillner J., Pastrana D.V., Buck C.B., Hinkula J., Wahren B., and Schwartz S. HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses. Virology 322 (2004) 182-189
35. Royds J.A., Hibma M., Dix B.R., Hananeia L., Russel I.A., Wiles A., Wynford-Thomas D., and Braithwaite A.W. p53 promotes adenoviral replication and increases late viral gene expression. Oncogene 25 (2006) 1509-1520
36. Rush M., Zhao X., and Schwartz S. A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression. J. Virol 79 18 (2005) 12002-12015
37. Schwartz S. HPV-16 RNA processing. Front. Biosci. 13 (2008) 5880-5891
38. Schwartz S., Felber B.K., and Pavlakis G.N. Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing. Virology 183 2 (1991) 677-686
39. Schwartz S., Somberg M., Zhao X., Rush M., Öberg D., Cassidy H., Fay J., and Lambkin H. Regulation of HPV gene splicing and expression. In: Norrild B. (Ed). Human Papillomavirus Gene Regulation and Transformation (2007), Transworld Research Network 47-67
40. Shtrichman R., Sharf R., Barr H., Dobner T., and Kleinberger T. Induction of apoptosis by adenovirus E4orf4 protein is specific to transformed cells and requires an interaction with protein phosphatase 2A. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 10080-10085
41. Sokolowski M., Zhao C., Tan W., and Schwartz S. AU-rich mRNA instability elements on human papillomavirus type 1 late mRNAs and c-fos mRNAs interact with the same cellular factors. Oncogene 15 19 (1997) 2303-2319
42. Sokolowski M., Tan W., Jellne M., and Schwartz S. mRNA instability elements in the human papillomavirus type 16 L2 coding region. J. Virol. 72 2 (1998) 1504-1515
43. Somberg M., Zhao X., Fröhlich M., Evander M., and Schwartz S. PTB induces HPV-16 late gene expression by interfering with splicing inhibitory elements at the major late 5′-splice site SD3632. J. Virol. 82 (2008) 3665-3678
44. Stewart S.A., Poon B., Jowett J.B., Xie Y., and Chen I.S. Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells. Proc. Natl. Acad. Sci. U. S. A. 96 21 (1999) 12039-12043
45. Terhune S.S., Hubert W.G., Thomas J.T., and Laimins L.A. Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression. J. Virol. 75 (2001) 8147-8157
46. Terhune S.S., Milcarek C., and Laimins L.A. Regulation of human papillomavirus 31 polyadenylation during the differentiation-dependent life cycle. J. Virol. 73 (1999) 7185-7192
47. Törmänen H., Backstrom E., Carlsson A., and Akusjärvi G. L4-33K, an adenovirus-encoded alternative RNA splicing factor. J. Biol. Chem. 281 48 (2006) 36510-36517
48. Wiklund L., Sokolowski M., Carlsson A., Rush M., and Schwartz S. Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability in the HPV-1 late 3′ untranslated region. J. Biol. Chem. 277 (2002) 40462-40471
49. Wu J.Y., and Maniatis T. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell 75 6 (1993) 1061-1070
50. Zhao X., and Schwartz S. Inhibition of HPV-16 L1 expression from L1 cDNAs correlates with the presence of hnRNP A1 binding sites in the L1 coding region. Virus Genes 36 (2008) 45-53
51. Zhao X., Rush M., and Schwartz S. Identification of an hnRNP A1 dependent splicing silencer in the HPV-16 L1 coding region that prevents premature expression of the late L1 gene. J. Virol. 78 (2004) 10888-10905
52. Zhao X., Öberg D., Rush M., Fay J., Lambkin H., and Schwartz S. A 57 nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFIP1, CstF-64, hnRNP C1/C2 and PTB. J. Virol. 79 (2005) 4270-4288
53. Zhao X., Fay J., Lambkin H., and Schwartz S. Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers. Virology 369 (2007) 351-363
54. Zheng Z.M., and Baker C.C. Papillomavirus genome structure, expression, and posttranscriptional regulation. Front. Biosci. 11 (2006) 2286-2302
55. Zheng Z.M., Tao M., Yamanegi K., Bodaghi S., and Xiao W. Splicing of a cap-proximal human papillomavirus 16 E6E7 intron promotes E7 expression, but can be restrained by distance of the intron from its RNA 5′ cap. J. Mol. Biol. 337 (2004) 1091-1108
56. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 5 (2002) 342-350